KayaAKeskinMTatlisuMAKayapinarO. Effect of dynamic potassium change on in-hospital mortality, ventricular arrhythmias, and long-term mortality in STEMI. Angiology. 2019;70(1):69–77.
2.
PatelRBTannenbaumSViana-TejedorA. Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36. Eur Heart J Acute Cardiovasc Care. 2017;6(1):18–25.
3.
KafkaHLangevinLArmstrongPW. Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. Arch Intern Med. 1987;147(3):465–9.
4.
SolomonRJColeAG. Importance of potassium in patients with acute myocardial infarction. Acta Med Scand Suppl. 1981;647:87–93.
5.
MadiasJEShahBChintalapallyGChalavaryaGMadiasNE. Admission serum potassium in patients with acute myocardial infarction: its correlates and value as a determinant of in-hospital outcome. Chest. 2000;118(4):904–13.
6.
AntmanEMAnbeDTArmstrongPW. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110(5):e82–292.
7.
EnselbergCDSimmonsHGMintzAA. The effects of magnesium upon cardiac arrhythmias. Am Heart J. 1950;39(5):703–12.
8.
BurchGEGilesTD. The importance of magnesium deficiency in cardiovascular disease. Am Heart J. 1977;94(5):649–57.
9.
CeremuzynskiLGebalskaJWolkRMakowskaE. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Intern Med. 2000;247(1):78–86.
10.
BringhurstFRDemayMBKraneSMKronenbergHM. Bone and mineral metabolism in health and disease. LongoDLFauciASKasperDLHauserSLJamesonJLLoscalzoJ, eds. Harrison’s Principles of Internal Medicine. 18th ed. New York, NY: McGraw-Hill; 2012: Ch. 32.
11.
WilliamsonMASnyderLMWallachJB. Wallach’s Interpretation of Diagnostic Tests. 9th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2011.
12.
AdamopoulosCPittBSuiXLoveTEZannadFAhmedA. Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study. Int J Cardiol. 2009;136(3):270–7.
13.
FisetCKargacinMEKondoCS. Hypomagnesemia: characterization of a model of sudden cardiac death. J Am Coll Cardiol. 1996;27(7):1771–6.
14.
KhanAMLubitzSASullivanLM. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2013;127(1):33–8.
15.
PeacockJMOhiraTPostW. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2010;160(3):464–70.
16.
HuangCLKuoE. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007;18:2649–52.
17.
SchaeferTJWolfordRW. Disorders of potassium. Emerg Med Clin North Am. 2005;23(3):723–47.
18.
KostisJBSheltonBGosselinG. Adverse effects of enalapril in the studies of left ventricular dysfunction (SOLVD). Am Heart J. 1996;131(2):350–5.
19.
DanzigerJWilliamJHScottDJ. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int. 2013;83(4):692–9.
